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Secreted frizzled-related proteins (sFRPs) are modulators of Wnt signaling. This study was undertaken for definitive assessment of
contribution of different sFRPs in osteoblastic differentiation of mesenchymal progenitor cells and apoptosis of osteoblasts. Treatment
of C3H10T1/2 cells with sFRP-2 at concentrations of 10, 50, and 100 nM and sFRP-4 at low concentrations (5 nM) significantly
increased Wnt-3A-induced alkaline phosphatase (ALP) activities, whereas sFRP-1 or 3 did not. Retroviral transduction of the sFRP-
2 but not other sFRPs also significantly enhanced ALP activity induced by b-glycerophosphate and ascorbic acid. Furthermore, trans-
fection of all the sFRP expression vectors significantly increased b-catenin/TCF reporter activity and the effects were most prominent
with sFRP-2 and -4. In osteoblast apoptosis assay, only sFRP-3 increased etoposide-induced apoptosis in MC3T3-E1 mouse osteoblasts.
In conclusion, we found that different repertoires of sFRPs exert differential effects on osteoblastic differentiation of mouse mesenchymal
cells and cellular apoptosis of mouse osteoblasts in vitro.
 2007 Elsevier Inc. All rights reserved.
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various normal and pathological developmental process of
many organs including bone (for review see Ref. [1]). In the
canonical Wnt/b-catenin pathway, binding of Wnt proteins
to the frizzled receptors activates the intracellular Dishev-
elled, which inhibits the kinase activity of a complex con-
taining glycogen synthetase kinase-3, Axin, b-catenin,
and other proteins [2]. Since these complex targets b-cate-
nin for rapid degradation through phosphorylation, Wnt
signaling allows the stabilization, and nuclear translocation
of b-catenin. b-Catenin then binds to TCF/LEF family of
transcription factors to regulate the expression of Wnt tar-
get genes [1].0006-291X/$ - see front matter  2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.bbrc.2007.12.128
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E-mail address: csshin@snu.ac.kr (C.S. Shin).Growing number of evidences suggest that Wnt signal-
ing plays a critical role in the regulation of bone accrual
during growth and the establishment of peak bone mass
as well as bone remodeling. A point mutation (G171V) at
the b-propeller module of LRP5, a Wnt co-receptor, results
in high bone mass phenotype, whereas targeted disruption
of LRP5 in mice or inactivating mutation in human leads
to decreased bone formation [3]. Wnt5a is required for lon-
gitudinal skeletal outgrowth and both Wnt5a and Wnt5b
regulate the transition between different chondrocyte zones
[4].
Activity of Wnt signaling pathway is regulated by
secreted inhibitors, including secreted frizzled-related pro-
tein (sFRP) [5], Wnt inhibitory factor-1 (WIF-1) [6], and
Dickkopf (Dkk) [7]. The sFRP family has an amino-termi-
nal cysteine-rich domain (CRD) that has high homology
with the ligand-binding domain of frizzled Wnt receptor
400 S.W. Cho et al. / Biochemical and Biophysical Research Communications 367 (2008) 399–405[8]. sFRPs bind directly to the Wnts proteins and appear to
antagonize the effects of Wnts by sequestering them from
their receptor. The inhibitory role of sFRPs on Wnt signal-
ing in mesenchymal differentiation was supported by the
finding that treatment of 3T3-L1 preadipocytes with
sFRP-1 or sFRP-2 resulted in spontaneous differentiation
to adipocytes in contrast to the inhibitory role of Wnt in
adipogenesis [9]. However, the role of sFRPs in osteoblasts
is still elusive. Although overexpression of sFRP-1 in
human osteoblasts has been shown to antagonize Wnt sig-
naling and accelerates apoptosis [10], a recent report dem-
onstrated that sFRP-3 is a potent stimulator of osteoblast
differentiation [11].
This study was undertaken for definitive assessment of
contribution of a series of sFRPs on osteoblastic differenti-
ation from mesenchymal progenitors using a murine mes-
enchymal C3H10T1/2 cell line. We have also investigated
the effects of sFRPs on the cellular apoptosis of MC3T3-
E1, a mouse calvaria-derived osteoblastic cell line.
Materials and methods
Materials. Recombinant human sFRP-1, 3, 4, Dkk-1, and mouse
sFRP-2 were purchased from R&D system (Minneapolis, MN). Mono-
clonal anti-HA antibody (MMS 101-P) was obtained from Covance Inc.
(Princeton, NJ). TOPflash plasmid which contains eight copies of the
optimal Tcf motif CCTTTGATC upstream of a minimal thymidine kinase
promoter driving luciferase expression and FOPflash plasmid that con-
tains a mutated motif CCTTTGGCC of the Tcf-Lef-sensitive elements
were obtained from Dr. Roberto Civitellli (Washington University, St.
Louis). Western blotting detection reagents and [a-32P]dCTP from
Amersham Int. (Buckinghamshire, UK). Random priming kits and
reagents for the luciferase assay were purchased from Promega Corp.
(Madison, WI) and Lipofectamine Plus from Invitrogen Corp. (Carlsbad,
CA). Oligonucleotides were synthesized by Bioneer Corp. (Chungwon,
Korea), and unless otherwise indicated, all other chemicals, including
tissue culture medium, were from Sigma–Aldrich Chemical company (St.
Louis, MO).
Cell culture. Murine mesenchymal cells C3H10T1/2 (American Type
Culture Collection, Manassas, VA) are pluripotent cells and were grown in
Dulbecco’s Modified Eagle Medium (DMEM) containing 10% FBS.
During osteoblastic differentiation studies, C3H10T1/2 cells were cultured
in DMEM with 10% FBS supplemented with either Wnt-3A conditioned
medium or 50 lg/ml ascorbic acid and 10 mM b-glycerophosphate. The
mouse MC3T3-E1 osteoblastic cells (RIKEN cell bank, Tsukuba, Japan)
were derived from spontaneously immortalized calvaria cells [12] and
maintained in DMEM medium with 10% FBS. The 3T3-L1 pre-adipocytic
cell line was a kind gift from Dr. Jae Bum Kim (Seoul National Univer-
sity, Seoul, Korea) and maintained in an immature state by culturing in
DMEM supplemented with 20% FBS and 2.0 mM glutamine. Normal
mouse osteoblasts were isolated from 21-day-old fetal mouse calvariae
using a well-characterized technique essentially as described previously
[13].
Preparation of Wnt-3A conditioned media (CM). L Wnt-3A [14] cells,
that stably secrete biologically active mouse Wnt-3A were grown in
DMEM supplemented with 10% FBS, 4 mM L-glutamine supplemented
with 0.4 mg/ml G-418. Upon reaching 80% confluence, cells were washed
once with PBS and transferred into DMEM containing 2% FBS, 1·
penicillin/streptomycin, and 4 mM L-glutamine. Conditioned media (CM)
was collected 1-day past confluence. We refer to the concentration of this
media to be 1·. The concentration of active Wnt-3A in the 1· Wnt-3A
CM is estimated to be 5 nM [15].
Retroviral vector construction. The mouse sFRP-1, 2, 3, and 4 cDNAs
were obtained from Dr. Jeremy Nathans (Johns Hopkins University,Baltimore, MD). The mouse Dkk-1 cDNAs was a kind gift from Dr.
Christof Niehrs (Deutsches Krebsforschungszentrum, Heidelberg, Ger-
many). A hemagglutinin (HA) epitope was incorporated at the C-terminal
of sFRPs using PCR, then ligated into the BglII/EcoRI site of the
pMSCV-GFP plasmid (a kind gift from Dr. Neil A. Clipstone at the
Northwestern University, Chicago, IL), upstream of internal ribosomal
entry site (IRES), giving pMSCV-sFRP-1–4-HA-GFP, and pMSCV-Dkk-
1-HA-GFP. The nucleotide sequences of the amplified sFRP coding
region were confirmed by sequencing.
Retrovirus production and transduction of cell lines. To generate retro-
viral particle, 293T cells were transfected with DNA (4 lg pMD-gag-pol,
4 lg pMD-VSVG, and 4 lg retroviral vector pMSCV-sFRP-1–4-HA-
GFP, pMSCV-Dkk-1-HA-GFP, or pMSCV-GFP alone), lipofectamine
PLUS, and serum-free DMEM. Viral supernatant fractions were collected
at 48 h and transduced into C3H10T1/2 cells as described previously [16].
Transduced cells expressing higher level of GFP were sorted using FACS
(FACSVantage SE, Beckton-Dickinson) and used for studies.
Alkaline phosphatase (ALP) activity. To assess ALP activities, cells
were washed three times with ice-cold Tris-buffered saline (TBS), pH 7.4
and scraped immediately after adding 0.5 mL of ice-cold 50 mM TBS; the
collected lysates were then sonicated for 20 s at 4 C. Enzyme activity
assay was performed in assay buffer (10 mM MgCl2 and 0.1 M alkaline
buffer, pH 10.3) containing 10 mM p-nitrophenylphosphate as substrate.
The reaction was stopped by adding 0.3 N NaOH absorbance was read at
OD405. Relative ALP activity is defined as mmol of p-nitrophenol phos-
phate hydrolyzed per min per mg of total protein.
RT-PCR. First-strand cDNA was synthesized from 1 lg of total RNA
using a Reverse Transcription System kit (Promega, Madison, WI). PCR
was performed using 100 ng of cDNA, 20 pmol of each primer (synthe-
sized by Bioneer Corp., Chungwon, Korea), 2.5 mM of dNTPs, 1 mM of
MgCl2, and 1 U of Taq polymerase in a 50 ll reaction volume containing
1· Taq polymerase buffer using a Perkin-Elmer Gene Amp PCR System
9600. The forward and reverse primer sequences used to amplify sFRPs
and b-actin are listed in Supplementary Table 1.
Transfections and reporter assays. For these experiments, C3H10T1/2
cells were seeded into 24-well plates at 50,000 cells/well. Twenty-four
hours later, TOPflash or FOPflash plasmid was cotransfected with
expression vectors for sFRP-1–4 or Dkk-1 in the presence or absence of
Wnt-3A CM. Forty-eight hours later, cell lysates were prepared using the
Promega Luciferase assay system, and activity was measured using a
luminometer (Lumat LB 9507, Berthold, Germany). All the transient
transfections were performed in triplicate and all luciferase values were
normalized against the b-galactosidase activities from the cotransfected
pCMV-b-gal plasmid. All values, means and standard deviations were
expressed relative to basal promoter activity as a fold induction.
Western blot analysis. Cells were lysed in 50 mM Tris (pH 7.5),
150 mM NaCl, and 1% Triton X-100 supplemented with a protease
inhibitor mixture (Sigma, added at a dilution of 1:100). Lysates were
separated by SDS–PAGE, and transferred to a Hybond ECL nitrocellu-
lose membrane (Amersham, Piscataway, NJ). The membrane was first
blocked with 5% milk for 1 h, and then incubated with primary and sec-
ondary antibodies for 24 and 1 h, respectively. Development of the
membrane was performed using an enhanced chemiluminescence kit
(Amersham, Piscataway, NJ).
Quantification of apoptosis. MC3T3-E1 cells were cultured in serum-
starved condition for 24 h, and sequentially treated with 20 nM of
sFRP-1, 2, 3, or 4 for 1 h. Apoptosis was induced by the addition of
etoposide (103 M) (Sigma–Aldrich Chemical company, St. Louis, MO)
for 10 h and the extent of apoptosis was quantified by assessing the
characteristic nuclear, i.e., chromatin condensation and nuclear frag-
mentation, by using the 4 0,6-diamidino-2-phenylindole dihydrochloride
(DAPI, Sigma–Aldrich, St. Louis, MO) staining under the fluorescence
microscope.
Statistical analysis. All data are presented as means ± SD. The data
were analyzed by one-way ANOVA. When the ANOVA indicated a sig-
nificant difference among the groups, statistical differences between two
groups were evaluated by Student–Newman–Keuls multiple comparison
test. A p value <0.05 was considered significant for all statistical analyses.
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Expression of sFRPs in murine cells of mesenchymal origin
We first investigated the endogenous expression of
sFRPs in a number of murine cells of mesenchymal origin
by RT-PCR analysis; pluripotent mesenchymal C3H10T1/
2, osteoblastic MC3T3-E1, myoblastic C2C12, pre-adipo-
cytic 3T3-L1, and primary cultures of mouse calvaria.
Expected cDNA fragments corresponding to mouse
sFRP-1, 2, 3, 4 were clearly amplified from RNA of these
cells (Fig. 1A). The expression level of sFRP-1 was the
highest in MC3T3-E1 cells whereas both sFRP-2 and -4
were most highly expressed in C2C12 cell compared to
other cell types. The expression of sFRP-3 was comparable































Fig. 1. Expression of sFRPs in mesenchymal cells and effect of sFRPs on the AL
for sFRP-1, 2, 3, 4, and b-actin were performed from reverse-transcribed total R
3T3-L1 cells, myoblastic C2C12 cells, osteoblastic MC3T3-E1 cells, and mouse
plate and grown for 72 h in DMEM containing 10% FBS and treated with ve
absence of Wnt-3A. ALP activity was determined and normalized to protein
performed in triplicate. Each bar represents means ± SD. *p < 0.05 vs. vehicleEffects of sFRP treatment on osteoblastic differentiation of
C3H10T1/2 cells
When C3H10T1/2 cells were treated with 0.5· Wnt-3A
conditioned media (CM) for 72 h, the ALP activity was
increased by 10- to 25-folds (Fig. 1B, Wnt-3A) as expected.
Co-treatment with 5–100 nM of sFRP-1, 2, 3, or 4 in this
setting, however, did not significantly inhibit the ALP
activity (Fig. 1B). Actually, sFRP-2 at concentrations of
10, 50, and 100 nM (Fig. 1B-b) and sFRP-4 at low concen-
trations (5 nM, Fig. 1B-d) significantly increased ALP
activities. The effects of sFRPs on ALP activity did not
seem to have any dose-responsive pattern. In contrast, in
a parallel experiment, the treatment with Dkk-1, a robust
inhibitor of Wnt signaling, has consistently inhibited the






































































































































P activities induced by Wnt-3A in C3H10T1/2 cells. (A) RT-PCR analysis
NA prepared from primary culture of calvarial osteoblasts, pre-adipocytic
mesenchymal C3H10T1/2 cells. (B) C3H10T1/2 cells were seeded in 24-well
hicle or varying concentrations of sFRP-1–4 or Dkk-1 in the presence or
content. The results are representative of three independent experiments
.
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differentiation of C3H10T1/2 Cells
To further verify the role of sFRPs in the osteoblastic
differentiation of mesenchymal cells, we studied the effects
of the sFRPs treatment during cultures in osteogenic med-
ium, i.e., b-glycerophosphate and ascorbic acid, a more
physiologic stimulator of osteoblastic differentiation. We
used stable cell lines that endogenously overexpressed
sFRPs in C3H10T1/2 cells using retrovirus. In this model,
the overexpressed sFRPs are expected to work by autocrine
and/or paracrine mechanism. The expression of sFRPs
were examined by Western blot analysis using an antibody
directed against the HA epitope (Fig. 2A).
As expected, culture of C3H10T1/2 cells transduced
with empty virus (MSCV) in osteogenic medium for 14
days exhibited typical induction of ALP activity
(Fig. 2B). Overexpression of sFRP-2 in this condition
resulted in significant increase in the ALP activity on day
14 of culture, whereas other sFRPs did not. These results
are analogous with the data we obtained from the exoge-
nous treatment of the cells with sFRPs in the presence of
Wnt-3A CM and suggest that the effects of sFRPs are
not necessarily negative in the regulation of osteoblastic
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Fig. 2. Effect of sFRP retrovirus on the ALP activities induced by osteogenic
retrovirus. Western blot analyses were performed using antibodies against HA
Dkk-1 retrovirus were seeded in 24-well plate and grown in DMEM containin
acid for 14 days. ALP activity was determined and normalized to protein c
performed in triplicate. Each bar represents means ± SD. *p < 0.05 vs. vehicleEffect of sFRPs on Wnt-b-catenin transcriptional activity
We next examined the effects of sFRPs on the b-catenin/
Tcf transcriptional activity, a downstream target of the
Wnt signaling. Transient transfection of TOPflash in
C3H10T1/2 cells showed only a basal level of transactiva-
tion, and this activity was increased by 8-fold with the
treatment with Wnt-3A CM (Fig. 3). Co-transfection with
sFRP-1, -2, -3, or sFRP-4 expression plasmid in this setting
resulted in significant increase in the transcriptional activ-
ity. Among the sFRPs, sFRP-2 and -4 exhibited most
strong responses. As a control, Dkk-1 significantly inhib-
ited the reporter activity as expected. Same experiments
performed using the FOPflash reporter did not reveal any
changes regardless of treatment with Wnt-3A.
Effect of sFRPs on apoptosis of osteoblastic MC3T3-E1 cells
Since none of the sFRPs has negatively regulated osteo-
blastic differentiation of mesenchymal C3H10T1/2 cells, we
next evaluated whether sFRPs increases apoptosis of oste-
oblasts thereby contributing to net loss of bone as has been
reported in sFRP-1 transgenic model [17]. Towards this
end, we treated topoisomerase inhibitor etoposide to




























medium. (A) C3H10T1/2 cells transduced with sFRP-1, 2, 3, 4, or Dkk-1
epitope. (B) C3H10T1/2 cells stably transduced with sFRP-1, 2, 3, 4, or
g 10% FBS in the presence or absence of b-glycerophosphate and ascorbic


















































Fig. 3. Effect of sFRPs on the TOPflash activities induced by Wnt-3A in
C3H10T1/2 cells. C3H10T1/2 cells were co-transfected with sFRP-1, 2, 3,
4, or Dkk-1 expression vectors and TOPflash or FOPflash plasmid. Forty-
eight hours after transfection, luciferase activity was measured and
normalized for transfection efficiency against b-galactosidase activity from
the co-transfected pCMV-b-gal plasmid. Values are presented as
means ± SD, and results are representative of three experiments each
performed in triplicate. Each bar represents means ± SD. *p < 0.05 vs.
MSCV.
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ing showed that only sFRP-3 significantly increased etopo-
side-induced apoptosis in mouse osteoblastic cells (Fig. 4),
whereas other subtypes did not affect cell death.
Discussion
In this study we have shown that the major secretary
Wnt modulators, sFRPs, including sFRP-1, 2, 3, and 4,
did not inhibit the Wnt-3A-mediated increase in ALP
activities in C3H10T1/2 mesenchymal cells in vitro. On

























Fig. 4. Effect of sFRPs on apoptosis in MC3T3-E1 cells. After 24 h serum-starv
and Dkk-1 for 1 h and then 103 M of etoposide was added. After 24 h, ap
(DAPI) staining and fluorescence microscopy. The results are representative of
means ± SD. *p < 0.05 vs. vehicle.We have found that all the mesenchymal cell lines
express varying degree of sFRP expression. These results
initially suggested that these molecules may serve physio-
logic functions in these cells as an auto- or paracrine mod-
ulators of Wnt signaling. We hypothesized that sFRPs, by
binding directly to the Wnts proteins and disrupting of
Wnt/b-catenin signaling, would inhibit the osteoblastic dif-
ferentiation. However, in our study we were unable to iden-
tify the negative roles of sFRPs in the ALP activity induced
by Wnt-3A in C3H10T1/2 cell line. Indeed, both sFRP-2
and -4 have significantly enhanced ALP activity at low con-
centrations, and at higher concentrations (>=50 nM),
sFRP-2 has consistently increased ALP activities. This lack
of inhibitory effects by all the sFRPs was also reproduced
when we transduced the cells with retrovirus rendering
the cells to produce sFRPs endogenously. This approach
was employed because sFRPs tend to remain predomi-
nantly associated with the cell membrane or extracellular
matrix [18]. In addition, transduction of sFRP-2 retrovirus
has also resulted in increase in ALP activities compared to
control virus. Therefore, the results from the retroviral
transduction study further confirm that even endogenously
secreted sFRPs that should have autocrine or paracrine
effects, do not inhibit the osteoblastic differentiation capa-
bilities in these C3H10T1/2 cells.
The lack of inhibition and even enhancement of ALP
activity by sFRPs (sFRP-2 and -4) in our experiments is
an unexpected result. The reason for this discrepancy with
previous reports is currently unknown. One explanation
might be that the sFRPs may have differential effects
depending on the concentration. Indeed, Uren and his
co-worker showed that sFRP-1 reduces Wingless (Wg,
Drosophila homolog of Wnt) activity only at high concen-
trations around 300–600 nM [19] whereas at low concen-
trations it potentiates Wg activity in Drosophila S2 cells
[19]. Moreover, Chung et al. also showed that sFRP-3 at
a concentration of 10 nM increased Wnt-3A-mediated














ed culture, MC3T3-E1 cells were pretreated with 20 nM of sFRP-1, 2, 3, 4,
optosis was quantified by 4 0,6-diamidino-2-phenylindole dihydrochloride
three independent experiments performed in triplicate. Each bar represents
404 S.W. Cho et al. / Biochemical and Biophysical Research Communications 367 (2008) 399–405may have stage-specific effects on the osteoblast differenti-
ation with little or no effects on undifferentiated mesenchy-
mal stage but significant effects on pre-osteoblasts or
mature osteoblasts in vitro [17]. Lastly, there may be some
specificity in interactions between particular sFRPs and
Wnt molecules so that the sFRPs are not capable to specif-
ically inhibit the action of Wnt-3A. In support of this
notion, Wang et al. has demonstrated that sFRP-3 (Frzb-
1) is not able to inhibit the action of Wnt-3A or -5A,
whereas it inhibits Wnt-1 or -8 [20], suggesting that sFRPs
modulates Wnt activity depending on the subtypes of both
Wnt and sFRPs.
We have also shown that all the sFRPs increased TOP-
flash activity induced by Wnt-3A. Moreover, the promi-
nent effects by sFRP-2 and -4 suggest that the increase in
ALP activities by both of sFRPs may result from the
increased b-catenin/Tcf transcriptional activities. However,
although ALP is one of the downstream targets of Wnt sig-
naling [21], we have not further dissected molecular mech-
anisms whereby sFRPs exerted ALP activities and
osteoblastic differentiation. Additional studies on the
ligand and receptor-binding activities and the events down-
stream of frizzled receptors could help answer this
question.
Since sFRPs did not inhibit osteoblastic differentiation
of mesenchymal progenitors, we next reasoned that these
secretary modulators may promote apoptosis of mature
osteoblasts. This is based on the previous in vivo demon-
stration of increased apoptosis of osteoblasts in sFRP-1
overexpressing mice [17]. However, unlike the animal
model, only sFRP-3 promoted apoptosis induced by eto-
poside in our experiment. Although differences in the
experimental model preclude direct comparison, these
results also indicate that there are a lot of disparities in
the action of sFRPs depending on the study model and
subtypes.
In conclusion, we have shown that different repertoires
of sFRPs have differential effects on osteoblastic differenti-
ation and TCF/LEF transcriptional activities in murine
mesenchymal cells and also on the apoptosis of osteoblasts.
We speculate that the contradictory effects of sFRPs result
from difference in interactions between different sFRPs and
Wnts, diverse repertoires of Wnt molecules, and tissue-spe-
cific or stage-specific responses, as well as biphasic response
depending on the concentrations of sFRPs.
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